MDSpire - Takeaway
From the Journals
Clinical Guidelines

Can This Device Help Neurosurgeons Better Treat Normal Pressure Hydrocephalus — and More?

A Keck Medicine of USC neurointerventionalist discusses how a minimally invasive, endovascularly implantable cerebrospinal fluid shunt is the next-generation treatment for normal pressure hydrocephalus — and possibly more.

  • March 30, 2026

  • 4 min

Share

  • 1

    Normal pressure hydrocephalus causes gait instability, cognitive issues, and urinary incontinence.

  • 2

    Traditional treatment involves invasive placement of ventriculoperitoneal shunts.

  • 3

    New technology accesses cerebrospinal fluid via blood vessels.

  • 4

    Potential for medication delivery directly into the brain.

  • 5

    Clinical trials for new technology are underway at Keck Medicine.

  • 6

    May assist in monitoring cerebrospinal fluid without repeated spinal taps.

  • 7

    Could expand treatment options for children and other hydrocephalus types.

Original Source(s)

Can This Device Help Neurosurgeons Better Treat Normal Pressure Hydrocephalus — and More?

  • March 30, 2026

Related Content

Q&A: Your student loan questions, answered

More than 60 questions were asked by attendees during a webinar on the One Big Beautiful Bill Act and its implications for dentists.

GlycoRNA Comes into Focus with Mass Spectrometry Blueprint

New review maps analytical workflows to decode a surprising class of sugar-coated RNA

  • March 30, 2026

  • 2 min
Root Canal Treatment Linked to Metabolic Improvements

Longitudinal NMR metabolomics study suggests clearing apical periodontitis may reduce systemic inflammation and improve glucose and lipid profiles

  • March 30, 2026

  • 3 min